NCT01396265View on ClinicalTrials.gov

Drug Interaction Study With Rifampicin and Afatinib

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Conditions
Healthy
Interventions
DRUG

Afatinib

single dose

DRUG

Afatinib

single dose

DRUG

Rifampicin

multiple doses

Trial Locations (1)

Unknown

1200.152.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY